NCT06830720 2026-03-03
CAROLEEN
Novartis
Recruiting
Clinical Trials
12 trialsNCT06495164 2025-11-25
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Pfizer
Active not recruiting
NCT04681768 2025-09-26
Abemacare
Technical University of Munich
Completed
NCT07151911 2025-09-03
ROYAL
Azienda Ospedaliero-Universitaria di Modena
Recruiting
NCT07008508 2025-06-06
BRAVE-Cyclin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active not recruiting
NCT06805812 2025-02-03
PALMARES-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT06341283 2024-05-10
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
The Affiliated Hospital of Qingdao University
Not yet recruiting
NCT06367335 2024-04-16
ETIC
University of Milano Bicocca
Completed
NCT05789771 2023-03-31
ATLANT
Blokhin's Russian Cancer Research Center
Completed
NCT05153135 2021-12-21
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Novartis
Completed
NCT05141240 2021-12-16
A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
Novartis
Completed
NCT04852081 2021-04-21
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center
Unknown